| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.0061 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |